Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Acquired von Willebrand syndrome in patients with monoclonal gammopathy of undetermined significance investigated using a mechanistic approach.

Blood transfusion = Trasfusione del sangue - 1 Jan 2023

Galletta Eva, Galvanin Federico, Bertomoro Antonella, Daidone Viviana, Casonato Alessandra

Abstract excerpt

BACKGROUND: Acquired von Willebrand syndrome (AVWS) has been reported to occur in association with monoclonal gammopathy, usually of undetermined significance (MGUS). It may present as a type 1 or type 2 von Willebrand factor (VWF) defect depending on the patient's representation of large VWF multimers. MATERIALS AND METHODS: The mathematical model by Galvanin et al., already employed for studying inherited von...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Monoclonal Gammopathy of Undetermined Significance
Share to Paraproteinemias

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Share to von Willebrand Diseases

Share to von Willebrand Factor

Source

Open in PubMed Open full text

Identifiers

PMID: 34694218
DOI: 10.2450/2021.0121-21
PMCID: PMC9918387

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Acquired von Willebrand syndrome in patients with monoclonal gammopathy of undetermined significance investigated using a mechanistic approach.PMID 34694218Read ↗

Reduced von Willebrand factor survival in von Willebrand disease: pathophysiologic and clinical relevance.Semantic proximity Read ↗

Von Willebrand factor propeptide makes it easy to identify the shorter Von Willebrand factor survival in patients with type 1 and type Vicenza von Willebrand disease.Semantic proximity Read ↗

VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease.Semantic proximity Read ↗

Reduced survival of type 2B von Willebrand factor, irrespective of large multimer representation or thrombocytopenia.Semantic proximity Read ↗

Anti-C1 domain antibodies that accelerate factor VIII clearance contribute to antibody pathogenicity in a murine hemophilia A model.Semantic proximity Read ↗

Clearance of von Willebrand factorSemantic proximity Read ↗

Clearance mechanisms of von Willebrand factor and factor VIII.Semantic proximity Read ↗

A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers.Semantic proximity Read ↗

The factor VIII/von Willebrand factor ratio discriminates between reduced synthesis and increased clearance of von Willebrand factor.Semantic proximity Read ↗

Von Willebrand factor: molecular size and functional activity.Semantic proximity Read ↗

Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD).Semantic proximity Read ↗

Type 1 von Willebrand disease due to reduced von Willebrand factor synthesis and/or survival: observations from a case series.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.